Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against AgEagle Aerial Systems, Inc. (UAVS)

RADNOR, Pa., April 09, 2021 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Central District of California against AgEagle Aerial Systems, Inc. (NYSE: UAVS) (“AgEagle”) on behalf of those who purchased or acquired AgEagle securities between September 3, 2019 and February 18, 2021, inclusive (the “Class Period”).


Investor Deadline Reminder: Investors who purchased or acquired AgEagle securities


during the Class Period may,



no later than April 27, 2021



, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at

[email protected]; orclick https://www.ktmc.com/ageagle-aerial-systems-class-action-lawsuit?utm_source=PR&utm_medium=link&utm_campaign=eagle

AgEagle is a commercial drone company that is engaged in the design, engineering, and manufacturing of commercial drones, as well as in providing drone services and solutions to the agriculture industry.

Throughout the Class Period, AgEagle signaled to investors that AgEagle had partnered with Amazon.com, Inc. (“Amazon”) to manufacture and assemble drones for the delivery of consumer goods.

However, on October 14, 2020, news broke that Amazon did not have a partnership agreement with AgEagle, and in fact never did. The Wichita Business Journal published a story with the headline: “Exclusive: Who’s AgEagle’s big customer? We now know who it’s not.” The article reported that AgEagle was not partnering with Amazon.

The complaint alleges that, throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (1) AgEagle did not have a partnership with Amazon and in fact never had any relationship with Amazon; (2) rather than correct the public’s understanding about a partnership with Amazon, the defendants were actively contributing to the rumor that AgEagle had a partnership with Amazon; and (3) as a result, the defendants’ statements about AgEagle’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

AgEagle investors may, no later than April 27, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP, or other counsel, or may choose to do nothing and remain an absent class member.  A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.  In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class.  Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. 

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world.  The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars).  The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500 (toll free)
[email protected]



Fulcrum Therapeutics Presents Published Structure of Investigational Small Molecule FTX-6058 at the American Chemical Society (ACS) Spring 2021 Virtual Conference

Company initiates dosing in Phase 1 healthy volunteer multiple ascending dose (MAD) cohort

CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today presented the medicinal chemistry strategy for FTX-6058 at the First Time Disclosure Session at the American Chemical Society (ACS) Spring 2021 National Meeting. FTX-6058 is a highly potent orally bioavailable small molecule EED inhibitor for the potential treatment of select hemoglobinopathies, including sickle cell disease and β-thalassemia. The validation of EED as a fetal hemoglobin (HbF) inducer target for sickle cell disease was conducted using FulcrumSeek, Fulcrum’s proprietary product engine.

“We are pleased to report progress on our development of FTX-6058 including the first publication of the structure of this compelling EED inhibitor,” said Chris Moxham, Ph.D., Fulcrum’s chief scientific officer. “We believe that this oral, once-a-day therapy with an impressive preclinical pharmacological profile has the potential to provide a meaningful therapeutic benefit to patients with sickle cell disease and β-thalassemia. We are also excited to report initial PK results from the SAD cohort and that our Phase 1 trial in healthy volunteers continues to progress with initiation of the multiple ascending dose cohorts. We expect to report the full data from this Phase 1 trial mid-year.”

FTX-6058 inhibits PRC2 via binding to EED, which induces robust HbF protein expression in both cell and murine models. Increasing HbF has the potential to prevent or reduce disease-related pathophysiology and reduce the risk of recurring events such as vaso-occlusive crises and hemolysis. Preclinical data with FTX-6058 showed an increase in HbF levels up to approximately 30% of total hemoglobin, demonstrating the potential to have a significant impact in patients with sickle cell disease. Human genetic data further indicate that individuals with the sickle cell mutation and high HbF levels may have asymptomatic disease, underscoring the protective effect of increased HbF.

Fulcrum’s Phase 1 trial in healthy volunteers is evaluating the safety, tolerability and pharmacokinetics of FTX-6058. Dosing has been initiated in the randomized, double-blind, placebo-controlled, multiple ascending dose (MAD) cohorts of the trial. Dosing continues in the single ascending dose (SAD) portion. The company anticipates sharing data from this Phase 1 trial in mid-2021 and initiating a clinical trial in sickle cell patients by the end of 2021.

Today’s presentation, titled “Discovery of clinical candidate FTX-6058: a potent, orally bioavailable upregulator of fetal hemoglobin for treatment of sickle cell disease”, will be available in the “Publications” section of fulcrumtx.com.

About Sickle Cell Disease

Sickle cell disease (SCD) is a genetic disorder of the red blood cells caused by a mutation in the HBB gene. This gene encodes a protein that is a key component of hemoglobin, a protein complex whose function is to transport oxygen in the body. The result of the mutation is less efficient oxygen transport and the formation of red blood cells that have a sickle shape. These sickle shaped cells are much less flexible than healthy cells and can block blood vessels or rupture cells. SCD patients typically suffer from serious clinical consequences, which may include anemia, pain, infections, stroke, heart disease, pulmonary hypertension, kidney failure, liver disease and reduced life expectancy.

About FTX-6058

FTX-6058 is a highly potent small molecule inhibitor of Embryonic Ectoderm Development (EED) capable of inducing robust HbF protein expression in cell and murine models. Fulcrum believes the pharmacokinetics and human dose simulations support that FTX-6058 may be given as a once daily oral compound. The validation of EED as a target for sickle cell disease and the discovery of FTX-6058 as a novel HbF-inducing small molecule were conducted using Fulcrum’s proprietary product engine. Preclinical data with FTX-6058 showed an increase in HbF levels up to approximately 30% of total hemoglobin. Fulcrum has initiated a Phase 1 trial with FTX-6058 in healthy adult volunteers.

About Fulcrum Therapeutics

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum’s proprietary product engine identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. The company has advanced losmapimod to Phase 2 clinical development for the treatment of facioscapulohumeral muscular dystrophy (FSHD). Fulcrum has also advanced FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and beta thalassemia into Phase 1 clinical development.

Please visit www.fulcrumtx.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties, including statements regarding the development status of the Company’s product candidates, the potential advantages and therapeutic potential of Fulcrum’s product candidates, initiation and enrollment of clinical trials and availability of clinical trial data, and the Company’s ability to fund its operations with cash on hand. All statements, other than statements of historical facts, contained in this press release, including statements regarding the Company’s strategy, future operations, future financial position, prospects, plans and objectives of management, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in, or implied by, such forward-looking statements. These risks and uncertainties include, but are not limited to, risks associated with Fulcrum’s ability to obtain and maintain necessary approvals from the FDA and other regulatory authorities; continue to advance its product candidates in clinical trials; initiate and enroll clinical trials on the timeline expected or at all; correctly estimate the potential patient population and/or market for the Company’s product candidates; obtain, maintain or protect intellectual property rights related to its product candidates; manage expenses; and raise the substantial additional capital needed to achieve its business objectives. For a discussion of other risks and uncertainties, and other important factors, any of which could cause the Company’s actual results to differ from those contained in the forward-looking statements, see the “Risk Factors” section, as well as discussions of potential risks, uncertainties and other important factors, in the Company’s most recent filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company’s views as of the date hereof and should not be relied upon as representing the Company’s views as of any date subsequent to the date hereof. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.

Contact:

Investors:

Christi Waarich
Director, Investor Relations and Corporate Communications
[email protected]
617-651-8664

Stephanie Ascher
Stern Investor Relations, Inc.
[email protected]
212-362-1200

Media:

Kaitlin Gallagher
Berry & Company Public Relations
[email protected]
212-253-8881



Barrow survey: For first time, majority of Arizona parents won’t allow kids to play football

But number of parents who allow contact sports is rising

PHOENIX, April 09, 2021 (GLOBE NEWSWIRE) — For the first time, a majority of Arizona parents say they will forbid their kids to play football because of concussion concerns, according to a survey by Phoenix’s Barrow Neurological Institute.

But that attitude does not extend to contact sports in general – the percentage of parents who allow contact sports increased for the first time in three years, the survey found. And girls’ soccer participation is rising despite the relatively high concussion risks in that sport.

“Parents are clearly deciding that football has too much risk of concussion, but they don’t feel that way about contact sports,” says Dr. Javier Cárdenas, director of the Barrow Concussion and Brain Injury Center at Barrow Neurological Institute, which is part of Dignity Health St. Joseph’s Hospital and Medical Center. “It is true that football has the highest concussion rates, but they have been falling. It also may be a result of the media focus on concussion in football over the last several years.”

Football is considered a collision sport. Contact sports include soccer and basketball.

Each of the last five years, Barrow has measured the public’s awareness of concussion and how it impacts participation in high school athletics. Greater awareness of sport-related concussion has led to widespread concern over the long-term effects of brain injuries.

FOOTBALL NUMBERS PLUMMET

As the public has become more educated about sport-related concussion, the percentage of Arizona parents allowing football has steadily declined, from 68 percent in 2016 to 47 percent this year.

  • 2016: 68 percent of Arizona parents allowed their children to play football
  • 2017: 65 percent
  • 2018: 59 percent
  • 2019: 54 percent
  • 2020: 47 percent

That has resulted in a decrease in participation in high school football, although the sport still attracts the most players overall.

Arizona has led the nation in working to make all sports safer, especially football, with groundbreaking rules limiting tackling in practice and helmet dislodgement rule. Despite that, participation continues to fall. “I don’t see football participation increasing any time soon, but the numbers may ebb and flow,” Cárdenas says.

The percentage of parents who allowed contact sports dropped from 82 percent in 2017 to 74 percent in 2018 and 65 percent in 2019. This year, number grew slightly, to 71 percent.

GIRLS SOCCER REMAINS POPULAR DESPITE RISKS

Meanwhile, girls’ high school soccer participation in Arizona has climbed at virtually the same rate that football has declined – from 5,298 in 2008-09 to 6,489 in 2018-19. The state is also home to a thriving club soccer culture, with many girls playing the sport year-round.

The participation numbers remain high despite reports that girls’ soccer concussion rates approach those of football. A 2019 Pediatrics study of head trauma in high school sports found that girls’ soccer had the second rate of concussion, eight per 10,000 practices or games, behind only football, with 10 per 10,000 practices or games.

Overall, 84 percent of Arizona parents say they would allow their children to play soccer, consistent with previous surveys.

“While concussion rates are rising in soccer, especially girls’ soccer, they are still less than football,” Cárdenas says. “The gap is closing, in part because fewer athletes are playing football and the rates are falling, but there is still a gap.”

In soccer, concussions most often occur when players collide with each other, although some are a result of falling to the ground or colliding with the goal post.

CONCUSSION FATIGUE?

Efforts to educate teens on the danger of concussions appear to be paying dividends. Nine in 10 Arizona teens agree that concussions are a serious medical condition, consistent with previous surveys. But the percentage of athletes who say they would play through a concussion if the state title were on the line rose sharply, to 36 percent from 27 percent.

Cárdenas, a member of the Arizona Interscholastic Association’s medical advisory panel, says he is troubled by that statistic.

“Concussion prevention and safety appear to have taken a back seat to competition and winning,” he says. “Trying to play through a concussion is a terrible idea, and in rare cases it could be fatal.”

Cárdenas, who treats numerous student-athletes in his Barrow clinic, cited the possibility of “concussion fatigue” among teens. “People are constantly needing reminders,” he says. “Some may be tired of hearing about concussions.”

About one in three Arizona student-athletes reported sustaining a concussion while playing sports.

CONCUSSION EDUCATION PAYS DIVIDENDS

Arizona has been among the national leaders in concussion education for student-athletes. Barrow Brainbook has more than 1 million users entering its 10th year. More than 300,000 ImPACT baseline concussion tests have been administered to Arizona teen athletes. Barrow Brainbook was created by Dr. Cárdenas and launched in 2011 as the most comprehensive concussion education effort in Arizona. Brainbook is a web-based learning tool developed specifically for high school student-athletes that provides information on how to prevent, recognize and respond to concussions.

Improved understanding of concussion may be empowering teens to decide whether to play a sport. More than half of teens say that they alone made that decision, and those who called it a joint decision dropped sharply (to 28 percent from 43 percent last year).

“That was always its intent of Brainbook—it’s clear that teens are more informed when they make the choice to participate,” Cárdenas says. “We know that sports offer many health benefits. Our challenge is to make sure the public can weigh the benefits against injury risks and make informed decisions.”

The teens study was conducted in April 2020 with a sample of 301 males and females, ages 14 to 18, living in Arizona.  Of these, 228 reported playing school and / or club sports. The margin of error is plus or minus 5.6 percent at 95 percent confidence for the full sample (301), and plus or minus 6.5 percent among high school athletes (228).

The parents study was conducted in April 2020 with a sample of 601 Arizona adults selected randomly.  Of these, 200 were parents of a child or children under the age of 18. The margin of error for the different sample sizes is as follows: plus or minus 4.0 percent for the full sample (601) and plus or minus 6.9 percent among parents of teens.

— ### —



Carmelle Malkovich
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center
602-406-3319
[email protected]

Origin Bancorp, Inc. Announces First Quarter 2021 Earnings Release and Conference Call

RUSTON, La., April 09, 2021 (GLOBE NEWSWIRE) — Origin Bancorp, Inc. (Nasdaq: OBNK) (“Origin”), the financial holding company for Origin Bank, plans to issue first quarter 2021 results after the market closes on Wednesday, April 28, 2021, and hold a conference call to discuss such results on Thursday, April 29, 2021, at 8:00 a.m. Central Time (9:00 am Eastern Time). The conference call will be hosted by Drake Mills, Chairman, President and CEO, Steve Brolly, Chief Financial Officer, and Lance Hall, President and CEO of Origin Bank.

Conference Call and Live Webcast        
To participate in the live conference call, please dial (844) 695-5516; International: (412) 902-6750 and request to be joined into the Origin Bancorp, Inc. (OBNK) call. A simultaneous audio-only webcast may be accessed via Origin’s website at www.origin.bank under the Investor Relations, News & Events, Events & Presentations link or directly by visiting https://services.choruscall.com/links/obnk210429.html.

Conference Call Webcast Archive

If you are unable to participate during the live webcast, the webcast will be archived on the Investor Relations section of Origin’s website at www.origin.bank, under Investor Relations, News & Events, Events & Presentations.

About Origin Bancorp, Inc.

Origin is a financial holding company headquartered in Ruston, Louisiana. Origin’s wholly owned bank subsidiary, Origin Bank, was founded in 1912. Deeply rooted in Origin’s history is a culture committed to providing personalized, relationship banking to its clients and communities. Origin provides a broad range of financial services to businesses, municipalities, high net worth individuals and retail clients. Origin currently operates 44 banking centers located from Dallas/Fort Worth and Houston, Texas across North Louisiana and into Mississippi. For more information, visit www.origin.bank.

Contact Information

Investor Relations
Chris Reigelman
318-497-3177
[email protected]

Media Contact
Ryan Kilpatrick
318-232-7472
[email protected]



DDD INVESTOR ALERT: Rosen Law Firm Encourages 3D Systems Corp. Investors with Large Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by Firm – DDD

DDD INVESTOR ALERT: Rosen Law Firm Encourages 3D Systems Corp. Investors with Large Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by Firm – DDD

NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of 3D Systems Corp. (NYSE: DDD) between May 6, 2020 and March 1, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 8, 2021 in the securities class action lawsuit first filed by the firm.

SO WHAT: If you purchased 3D Systems securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the 3D Systems class action, go to http://www.rosenlegal.com/cases-register-2049.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 8, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) 3D Systems lacked proper internal controls over financial reporting; and (2) as a result, 3D Systems’ public statements were materially false and/or misleading at all relevant times.

To join the 3D Systems class action, go to http://www.rosenlegal.com/cases-register-2049.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Other Professional Services Professional Services Legal

MEDIA:

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Jianpu Technology Inc. Investors With Losses to Secure Counsel Before Important April 19 Deadline in Securities Class Action – JT

NEW YORK, April 09, 2021 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Jianpu Technology Inc. (NYSE: JT) between May 29, 2018 and February 16, 2021, inclusive (the “Class Period”), of the important April 19, 2021lead plaintiff deadline.

SO WHAT: If you purchased Jianpu securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Jianpu class action, go to http://www.rosenlegal.com/cases-register-2033.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 19, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) certain of Jianpu’s transactions carried out by the Credit Card Recommendation Business Unit involved undisclosed relationships or lacked business substance; (2) as a result, Jianpu’s revenue and costs and expenses for fiscal 2018 and 2019 were overstated; (3) there were material weaknesses in Jianpu’s internal control over financial reporting; (4) as a result of the foregoing, Jianpu’s fiscal 2018 Form 20-F was reasonably likely to be restated; and (5) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Jianpu class action, go to http://www.rosenlegal.com/cases-register-2033.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        [email protected]
        [email protected]
        www.rosenlegal.com



General Dynamics to Webcast 2021 First-Quarter Financial Results Conference Call

PR Newswire

RESTON, Va., April 9, 2021 /PRNewswire/ — General Dynamics (NYSE: GD) will webcast its first-quarter 2021 financial results conference call on Wednesday, April 28, 2021, beginning at 9 a.m. EDT.

The live webcast of the conference call will be available at www.gd.com. A replay will be available shortly after the live presentation.

More information about General Dynamics is available at www.gd.com.  

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/general-dynamics-to-webcast-2021-first-quarter-financial-results-conference-call-301265528.html

SOURCE General Dynamics

Luther Burbank Corporation Announces First Quarter 2021 Earnings Release and Conference Call Dates

SANTA ROSA, Calif., April 09, 2021 (GLOBE NEWSWIRE) — Luther Burbank Corporation (the “Company”) (NASDAQ: LBC), the holding company for Luther Burbank Savings (the “Bank”), announced today that it will release its financial results as of and for the quarter ended March 31, 2021 after the market closes on Tuesday, April 27, 2021.

Simone Lagomarsino, President and Chief Executive Officer of Luther Burbank Corporation, and Laura Tarantino, Executive Vice President and Chief Financial Officer, will host a conference call on Wednesday, April 28, 2021 at 8:00 AM (PT) to discuss the Company’s results for the period.

Analysts, investors, and the general public may listen to a discussion of the Company’s quarterly performance and a question/answer session by using the phone number or live webcast link listed below. The webcast will include a slide presentation that will be available for review and may be referenced during the call. It is recommended that participants dial into the conference call or log into the webcast approximately 10 minutes prior to the call.

Earnings Call Details

Date: April 28, 2021
Time: 8:00 AM (PT)
Phone Number: (877) 221-8769
Conference ID: 4081415
Webcast URL: https://edge.media-server.com/mmc/p/rk6iqtse

About Luther Burbank Corporation

Luther Burbank Corporation is a publicly owned company traded on the NASDAQ Capital Market under the symbol “LBC.” The Company is headquartered in Santa Rosa, California with total assets of $6.9 billion, total loans of $6.0 billion and total deposits of $5.3 billion as of December 31, 2020. It operates primarily through its wholly-owned subsidiary, Luther Burbank Savings, an FDIC insured, California-chartered bank. Luther Burbank Savings executes on its mission to improve the financial future of customers, employees and shareholders by providing personal banking and business banking services. It offers consumers a host of highly competitive depository and mortgage products coupled with personalized attention. Business customers benefit from boutique-quality service along with access to products which meet their unique financial needs from the convenience of online and mobile banking, robust cash management solutions, and high-yield liquidity management products to multifamily and commercial real estate lending. Currently operating in California, Oregon and Washington, from ten branches in California, one branch in Washington and seven lending offices located throughout the market area, Luther Burbank Savings is an equal housing lender. For additional information, please visit lutherburbanksavings.com.

Contact: Bradley Satenberg
  Investor Relations
  (844) 446-8201
  [email protected] 



AppSwarm to Launch Blockchain Research Lab in Tulsa and New York in Partnership with AI Venturetech

Tulsa, OK, April 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — AppSwarm, Corp. (OTC: SWRM), a software development company and aggregator of mobile applications, announces plans to launch a blockchain research lab in Tulsa, OK and New York City to develop new applications utilizing different blockchain protocols.

The Company announces plans to launch a Blockchain Research Lab and consulting firm in Tulsa, Oklahoma focused on the development and utilization of current blockchain protocols in partnership with AI Venturetech.

Blockchain is a decentralized transaction and data management technology. We will endeavor to partner with both commercial and academic partners to explore how this emerging industry can be deployed in real-world commercial applications.

Some areas of exploration will be in Decentralized finance (“DeFi”), non-fungible tokens (“NFT”), and smart contract development.

DeFi are financial services with no central authority. It involves taking traditional elements of the financial system and replacing the middleman with a smart contract, most commonly on the Ethereum blockchain.

NFT is a unit of data on a digital ledger called a blockchain, where each NFT can represent a unique digital item, and thus they are not interchangeable. NFTs can represent digital files such as art, audio, videos, items in video games, and other forms of creative work.

Research Lab in Tulsa

A coalition of Tulsa business, education, government, and philanthropists are working to foster a startup ecosystem in a city that’s better known for its aerospace and energy companies. Tulsa Remote provides workers a financial incentive and soft landing in a new city, as well as a thoughtful community-focused approach to attracting talented remote workers to Tulsa.

AppSwarm plans to work within Tulsa’s community to build on the foundation of the city’s current high-growth opportunities in technology and blockchain and attract top talent from around the country organically and through partnerships with local academic institutions.

The lab will embark on application research, seminars, blockchain workshops, and will utilize its video conferencing capabilities to bring together global minds and insights to Tulsa’s surging tech community.

New York Research Lab

The Company will also work in providing support to AI Venturetech for the launch of its blockchain research lab in the heart of New York City. The New York lab will work with local academic institutions and with commercial partners in both the financial and healthcare industries.

Thomas Bustamante, the Founder and CEO of AI Venturetech, Inc., commented, “We are pleased to be working with AppSwarm in the development of blockchain research labs in both New York, and especially Tulsa, which is one of the fastest-growing technology hubs in the Midwest. We feel real-world applications of blockchain could harness the growth potential of what the Internet was in the mid-1990s, and we want to establish our labs now to take advantage of this rapid change.”

The Company will offer blockchain consulting advisory services to companies looking to integrate blockchain technology. These consulting services, along with low overhead costs to maintain the lab could quickly provide a profitable operation if executed properly.

Request More Information

For more updates on our blockchain research project visit https://aiventuretech.com/investors/signup/

About APPSWARM

AppSwarm is a technology company specializing in accelerated development and publishing of mobile apps and other software platforms for gaming and business applications and seeks to acquire symmetric business opportunities. AppSwarm partners with and assists other development firms in technology development, business management, and funding needs.

For more information, follow us on www.app-swarm.com FaceBook www.facebook.com/AppSwarm Twitter https://twitter.com/AppSwarm or Instagram https://www.instagram.com/appswarm/

Forward-Looking Statements:

“Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking statements that are subject to risk and uncertainties including, but not limited to, the impact of competitive products, product demand, market acceptance risks, fluctuations in operating results, political risk, and other risks detailed from time to time in the Company’s filings with OTCMarkets.com and as required to the Securities and Exchange Commission. These risks could cause SWRM’s actual results to differ materially from those expressed in any forward-looking statements made by, or on behalf of, the Company.

Investor and Media Contacts:

AppSwarm, Corp.
888-886-8583
[email protected]

AI Venturetech
212-206-0984
[email protected]



New Look Vision Group Calls Special Shareholders’ Meeting for Going-Private Transaction

Special Meeting to be held on May 14, 2021 in Virtual-Only Format

MONTREAL, April 09, 2021 (GLOBE NEWSWIRE) — New Look Vision Group Inc. (“New Look Vision” or the “Company”) (TSX: BCI.TO) today announced that the Québec Superior Court has issued an interim order authorizing, among other things, the holding of a special meeting (the “Special Meeting”) of shareholders of New Look Vision (“Shareholders”) on May 14, 2021. At the Special Meeting, Shareholders will be asked to consider and, if deemed advisable, to adopt a special resolution (the “Arrangement Resolution”) approving the previously-announced statutory plan of arrangement under the Canada Business Corporations Act (the “Arrangement”) pursuant to which NL1 AcquireCo Inc. (the “Purchaser”), an entity created by a group composed of funds managed by FFL Partners, LLC (“FFL”), a San Francisco-based private equity firm, Caisse de dépôt et placement du Québec or one of its affiliates (“CDPQ”), and the Dr. H. Doug Barnes Family will acquire, for a purchase price of $50.00 in cash per share, all of the issued and outstanding Class A common shares of New Look Vision (the “Shares”).

Pursuant to the interim order, the Special Meeting will be held on May 14, 2021 at 10:00 a.m. (Montréal time). In light of ongoing public health concerns related to the COVID-19 pandemic and in order to comply with government decrees, the Special Meeting will be held in virtual-only format, conducted via live webcast. Shareholders will be able to participate and vote at the Special Meeting online regardless of their geographic location.

Shareholders of record as of the close of business on April 9, 2021 will be entitled to receive notice of, to participate in, and to vote at the Special Meeting. New Look Vision expects to begin the distribution and mailing of its management information circular and related meeting materials on or about April 16, 2021, at which time they will also be available on New Look Vision’s profile on SEDAR at www.sedar.com and on New Look Vision’s website at www.newlookvision.ca. Details on the virtual Special Meeting and how Shareholders can access the Special Meeting will be set out in the circular.

The Board of Directors of New Look Vision (the “Board”) based in part on the unanimous recommendation of an independent committee of the Board (the “Special Committee”) and after receiving legal and financial advice, has determined that the Arrangement is in the best interests of New Look Vision and fair to the Shareholders (other than the Rollover Shareholders in respect of the Rollover Shares, as these terms are defined in the plan of arrangement implementing the Arrangement, and CDPQ). The Board unanimously (with certain directors abstaining from voting) recommends that the Shareholders vote FOR the Arrangement Resolution.

Antoine Amiel (the President and Chief Executive Officer of the Company), 8104107 Canada Inc. (a company controlled by Mr. Amiel), W. John Bennett (the Chairman of the Company), Benvest Holdings Limited and Bennett Church Hill Capital Inc. (both companies controlled by Mr. Bennett), representing in the aggregate approximately 36.20% of the issued and outstanding Shares, have entered into irrevocable Support and Voting Agreements pursuant to which each has agreed to vote in favour of the Arrangement Resolution. In addition, each of the other directors of the Company holding Shares and certain executive officers of the Company alongside certain Shareholders related to such directors and executive officers, representing in the aggregate approximately 4.20% of the issued and outstanding Shares, have entered into revocable Support and Voting Agreements pursuant to which each has agreed to vote in favour of the Arrangement Resolution.

National Bank Financial Inc., acting as financial advisor to the Company, has provided the Special Committee and the Board, and PricewaterhouseCoopers LLP, acting as independent financial advisor to the Special Committee, has provided the Special Committee, with an opinion to the effect that, as of March 18, 2021, the consideration to be received by Shareholders in the Arrangement is fair, from a financial point of view, to such holders other than the Rollover Shareholders in respect of the Rollover Shares and CDPQ, in each case subject to the respective limitations, qualifications, assumptions, and other matters set forth in such opinions.

To become effective, the Arrangement Resolution must be approved by: (i) not less than 66 2/3% of the votes cast at the Special Meeting by Shareholders virtually present or represented by proxy and entitled to vote at the Special Meeting; and (ii) a simple majority of the votes cast at the Special Meeting by Shareholders virtually present or represented by proxy and entitled to vote at the Special Meeting, excluding for this purpose the Rollover Shareholders and related parties thereof and any other person required to be excluded pursuant to applicable Canadian securities regulations. The Arrangement is also subject to approval by the Québec Superior Court and it is anticipated that the Arrangement will be completed in the first half of 2021.

Shareholders of New Look Vision with questions regarding the Special Meeting should contact Laurel Hill Advisory Group, New Look Vision’s shareholder communications advisor, at 1-877-452-7184 (toll-free within North America) or at 1-416-304-0211 (outside of North America) or by email at [email protected].

About New Look Vision

New Look Vision is a leading provider of eye care products and services across Canada and has recently entered the United States market. The Company has retail sales of optical products which can be grouped into four principal categories: (i) prescription and non-prescription eyewear, (ii) contact lenses, (iii) sunglasses, protective eyewear and reading glasses, and (iv) accessories, such as cleaning products for eyeglasses and contact lenses. The Company’s network of stores totals 407 locations, operating mainly under the New Look Eyewear, Vogue Optical, Greiche & Scaff, Iris and Edward Beiner trade names. Certain prescription lenses are processed at the Company’s laboratory facility, located in Ville St-Laurent, Québec. For additional information please visit www.newlookvision.ca or consult our LinkedIn page.

About FFL Partners

Founded in 1997, FFL Partners is a San Francisco-based private equity firm with over US$4.5 billion under management. FFL pursues thematic investments in business services and healthcare services partnering with exceptional management teams where the firm’s high engagement operating model and extensive network can help accelerate growth and unlock value. Growing its businesses has provided over 75% of the value created by FFL for its investors. For additional information please visit www.fflpartners.com.

About CDPQ

At Caisse de dépôt et placement du Québec (CDPQ), we invest constructively to generate sustainable returns over the long term. As a global investment group managing funds for public retirement and insurance plans, we work alongside our partners to build enterprises that drive performance and progress. We are active in the major financial markets, private equity, infrastructure, real estate and private debt. As at December 31, 2020, CDPQ’s net assets total CA$365.5 billion. For more information, visit cdpq.com, follow us on Twitter or consult our Facebook or LinkedIn pages.

Caution Regarding Forward-Looking Statements

Certain statements made in this news release are forward-looking statements within the meaning of applicable securities laws, including, but not limited to, statements with respect to the timing of the closing of the Arrangement, and other statements that are not material facts. Often, but not always, forward-looking statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “plan”, “could”, “should”, “would”, “outlook”, “forecast”, “anticipate”, “foresee”, “continue” or the negative of these terms or variations of them or similar terminology.

Although the Company believes that the forward-looking statements in this news release are based on information and assumptions that are current, reasonable and complete, these statements are by their nature subject to a number of factors that could cause actual results to differ materially from management’s expectations and plans as set forth in such forward-looking statements, including, without limitation, the following factors, many of which are beyond the Company’s control and the effects of which can be difficult to predict: (a) the possibility that the proposed Arrangement will not be completed on the terms and conditions, or on the timing, currently contemplated, and that it may not be completed at all, due to a failure to obtain or satisfy, in a timely manner or otherwise, required shareholder, court and regulatory approvals and other conditions of closing necessary to complete the Arrangement or for other reasons; (b) risks related to tax matters; (c) the possibility of adverse reactions or changes in business relationships resulting from the announcement or completion of the Arrangement; (d) risks relating to the Company’s ability to retain and attract key personnel during the interim period; (e) the possibility of litigation relating to the Arrangement; (f) credit, market, currency, operational, liquidity and funding risks generally and relating specifically to the Arrangement, including changes in economic conditions, interest rates or tax rates; (g) business, operational and financial risks and uncertainties relating to the COVID-19 pandemic; and (h) other risks inherent to the Company’s business and/or factors beyond its control which could have a material adverse effect on the Company or the ability to consummate the Arrangement.

Readers are cautioned not to place undue reliance on the forward-looking statements and information contained in this news release. New Look Vision disclaims any obligation to update any forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by law.

For further information:

New Look Vision
+1 514 877 4119
[email protected]

FFL Partners
+1 415 402-2100
[email protected]

CDPQ
+1 514 847-5493
[email protected]